183 related articles for article (PubMed ID: 24023696)
1. Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
Taylor N; Grabmeier-Pfistershammer K; Egle A; Greil R; Rieger A; Ledergerber B; Oberkofler H
PLoS One; 2013; 8(8):e74024. PubMed ID: 24023696
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.
Garrett NJ; Apea V; Nori A; Ushiro-Lumb I; Oliver AR; Baily G; Clark DA
J Clin Virol; 2012 Apr; 53(4):354-5. PubMed ID: 22261125
[TBL] [Abstract][Full Text] [Related]
3. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.
Scott LE; Noble LD; Moloi J; Erasmus L; Venter WD; Stevens W
J Clin Microbiol; 2009 Jul; 47(7):2209-17. PubMed ID: 19420172
[TBL] [Abstract][Full Text] [Related]
5. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
[TBL] [Abstract][Full Text] [Related]
6. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.
Manavi K
HIV Clin Trials; 2008; 9(4):283-6. PubMed ID: 18753122
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
[TBL] [Abstract][Full Text] [Related]
8. Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.
Abubakar A; Ndembi N; Ogbanufe O; Inalegwu A; Wilson S; Ebagua I; Peters S; Chime C; Dakum P; Abimiku AG
Curr HIV Res; 2015; 13(4):262-7. PubMed ID: 25613132
[TBL] [Abstract][Full Text] [Related]
9. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
[TBL] [Abstract][Full Text] [Related]
10. Comparative frequencies of HIV low-level viremia between real-time viral load assays at clinically relevant thresholds.
Do T; Duncan J; Butcher A; Liegler T
J Clin Virol; 2011 Dec; 52 Suppl 1():S83-9. PubMed ID: 21995930
[TBL] [Abstract][Full Text] [Related]
11. Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.
Briggs R; Templeton K; Fernando I
Int J STD AIDS; 2014 Dec; 25(14):1029-34. PubMed ID: 24648315
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
[TBL] [Abstract][Full Text] [Related]
13. Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy.
Pascual-Pareja JF; Martínez-Prats L; Luczkowiak J; Fiorante S; Rubio R; Pulido F; Otero JR; Delgado R
J Clin Microbiol; 2010 May; 48(5):1911-2. PubMed ID: 20181895
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma.
Muenchhoff M; Madurai S; Hempenstall AJ; Adland E; Carlqvist A; Moonsamy A; Jaggernath M; Mlotshwa B; Siboto E; Ndung'u T; Goulder PJ
PLoS One; 2014; 9(8):e103983. PubMed ID: 25157919
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability.
Ruelle J; Debaisieux L; Vancutsem E; De Bel A; Delforge ML; Piérard D; Goubau P
BMC Infect Dis; 2012 Apr; 12():100. PubMed ID: 22530816
[TBL] [Abstract][Full Text] [Related]
16. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay.
Lima V; Harrigan R; Montaner JS
J Acquir Immune Defic Syndr; 2009 May; 51(1):3-6. PubMed ID: 19247185
[TBL] [Abstract][Full Text] [Related]
17. Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.
Garner W; White K; Szwarcberg J; McCallister S; Zhong L; Wulfsohn M
Clin Infect Dis; 2016 Apr; 62(7):929-934. PubMed ID: 26689956
[TBL] [Abstract][Full Text] [Related]
18. Performance Evaluation of the Bioneer AccuPower® HIV-1 Quantitative RT-PCR kit: Comparison with the Roche COBAS® AmpliPrep/COBAS TaqMan® HIV-1 Test Ver.2.0 for Quantification of HIV-1 Viral Load in Indonesia.
Kosasih AS; Sugiarto C; Hayuanta HH; Juhaendi R; Setiawan L
Asian Pac J Allergy Immunol; 2018 Jun; 36(2):120-125. PubMed ID: 28802027
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
Pyne MT; Brown KL; Hillyard DR
J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
[TBL] [Abstract][Full Text] [Related]
20. Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.
Álvarez Estévez M; Chueca Porcuna N; Guillot Suay V; Peña Monge A; García García F; Muñoz Medina L; Vinuesa García D; Parra Ruiz J; Hernández-Quero J; García García F
J Clin Microbiol; 2013 May; 51(5):1555-7. PubMed ID: 23390288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
